Patent details

EP3006038 Title: SINGLE DOSES OF ORITAVANCIN FOR TREATING OR PREVENTING A BACTERIAL INFECTION

Basic Information

Publication number:
EP3006038
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP151957263
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SINGLE DOSES OF ORITAVANCIN FOR TREATING OR PREVENTING A BACTERIAL INFECTION
French Title of Invention:
DOSES UNIQUES D'ORITAVANCINE POUR PRÉVENIR OU TRAITER UNE INFECTION BACTÉRIENNE
German Title of Invention:
ORITAVANCIN-EINZELDOSEN ZUR VORBEUGUNG ODER BEHANDLUNG EINER BAKTERIELLEN INFEKTION
SPC Number:

Dates

Filing date:
29/08/2009
Grant date:
03/07/2024
EP Publication Date:
13/04/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/07/2024
EP B1 Publication Date:
03/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/08/2024
Expiration date:
29/08/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/09/2024
 
 

Name:
Melinta Therapeutics, LLC
Address:
389 Interpace Parkway Suite 450, Parsippany, NJ 07054, United States (US)

History of Owners

From:
26/06/2024
To:
27/09/2024

Name:
The Medicines Company
Address:
8 Sylvan Way, Parsippany, NJ 07054, United States (US)

Inventor

1

Name:
LEHOUX, Dario
Address:
Canada (CA)

2

Name:
MOECK, Gregory
Address:
Canada (CA)

3

Name:
ETIENNE, Pierre
Address:
Canada (CA)

4

Name:
PARR, Thomas
Address:
United States (US)

Priority

1

Priority Number:
93314 P
Priority Date:
30/08/2008
Priority Country:
United States (US)

2

Priority Number:
93497 P
Priority Date:
02/09/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/14; A61P 31/04; A61P 17/00;

Publication

European Patent Bulletin

1

Issue number:
202427
Publication date:
03/07/2024
Description:
Grant (B1)

2

Issue number:
202432
Publication date:
07/08/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202444
Publication date:
30/10/2024
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages